ArticleMicrobial biotechnology2026
Plastics and Bioplastics End of Life: A Biocatalytic Perspective.
Article in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Plastics have become indispensable to modern society, but their predominantly linear production and end-of-life management are increasingly incompatible with environmental and resource constraints. Biotechnology offers new opportunities to reshape this system, not only by enabling the biological recycling and upcycling of conventional plastics, but also by supporting the production and end-of-life management of more sustainable bioplastics. Recent progress in plastic-degrading enzymes, particularly for PET, has demonstrated the potential of biocatalysis, yet it has also made clear that enzyme performance alone will not determine whether these technologies succeed at scale. Real waste streams, sorting and pretreatment requirements, process economics and integration with existing recycling infrastructure remain decisive constraints. The same systems perspective is needed for bioplastics: Bio-based origin or biodegradability does not automatically translate into circularity, and their environmental value ultimately depends on how materials are designed, used, collected and treated after use. In this Opinion, we argue that biocatalysis should therefore be developed as part of realistic circular plastic systems rather than as a universal solution to plastic waste. Combining advances in enzymatic and microbial technologies with Safe-and-Sustainable-by-Design principles and credible end-of-life pathways could enable plastics and bioplastics to move towards genuinely circular material cycles while reducing dependence on fossil carbon and limiting plastic pollution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.